Completed PHASE4 INTERVENTIONAL 2-arm NCT02486328

The Effect of Different Sedation Regimes on Cognitive Function in Lower Gastrointestinal System Endoscopy

The Effect of Different Sedation Regimes Administered by Anesthesiologists or Endoscopists on Cognitive Functions in Lower Gastrointestinal System Endoscopy

Sponsor: Ufuk University

Conditions Alteration of Cognitive Function Gastrointestinal Dysfunction

Interventions Meperidine Midazolam Propofol Remifentanil

Updated 9 times since 2017 Last updated: Aug 18, 2020 Started: May 31, 2015 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Alteration of Cognitive Function and Gastrointestinal Dysfunction and is currently completed. Ufuk University leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Oct 2020 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Oct 2020 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ufuk University

Data source: Ufuk University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.